Abstract:Copper (Cu), an essential micronutrient with redox properties, plays a pivotal role in a wide array of pathological and physiological processes across virtually all cell types. Maintaining an optimal copper concentration is critical for cellular survival: insufficient copper levels disrupt respiration and metabolism, while excess copper compromises cell viability, potentially leading to cell death. Similarly, in the context of cancer, copper exhibits a dual role: appropriate amount of copper can promote tumor progression and be an accomplice, yet beyond befitting level, copper can bring about multiple types of cell death, including autophagy, apoptosis, ferroptosis, immunogenic cell death, pyroptosis, and cuproptosis. These forms of cell death are beneficial against cancer progression; however, achieving precise copper regulation within tumors remains a significant challenge in the pursuit of effective cancer therapies. The emergence of nanodrug delivery systems, distinguished by their precise targeting, controlled release, high payload capacity, and the ability to co-deliver multiple agents, has revitalized interest in exploiting copper's precise regulatory capabilities. Nevertheless, there remains a dearth of comprehensive review of copper's bidirectional effects on tumorigenesis and the role of copper-based nanomaterials in modulating tumor progression. This paper aims to address this gap by elucidating the complex role in cancer biology and highlighting its potential as a therapeutic target. Through an exploration of copper's dualistic nature and the application of nanotechnology, this review seeks to offer novel insights and guide future research in advancing cancer treatment.

Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes

Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy

Potential of Copper and Copper Compounds for Anticancer Applications

Recent Advances in Copper Homeostasis-Involved Tumor Theranostics

Copper and Copper Complexes in Tumor Therapy

Harnessing nanomaterials for copper-induced cell death

Copper-mediated novel cell death pathway in tumor cells and implications for innovative cancer therapies

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies

Current state of research on copper complexes in the treatment of breast cancer

Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations

Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics

Copper in medicine: homeostasis, chelation therapy and antitumor drug design.

Copper As the Target for Anticancer Nanomedicine

Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies

The Copper Age in Cancer Treatment: from Copper Metabolism to Cuproptosis

Dissecting copper biology and cancer treatment: ‘Activating Cuproptosis or suppressing Cuproplasia’

Copper in cancer: from limiting nutrient to therapeutic target

Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review

Targeting copper metabolism: a promising strategy for cancer treatment

Cuproptosis: Harnessing Transition Metal for Cancer Therapy

Multifaceted Roles of Copper ions in Anticancer Nanomedicine